Feature|Articles|June 27, 2025

Biden’s prostate cancer diagnosis underscores importance of screening, awareness

Fact checked by: Benjamin P. Saylor, Strategic Content Lead

The unfortunate news of President Biden’s diagnosis has put a spotlight on prostate cancer, offering an opportunity to educate on the risks of the disease and the benefits of screening.

Former President Joseph R. Biden’s recent diagnosis of grade group 5 de novo metastatic hormone-sensitive prostate cancer has offered a sobering reminder that prostate cancer remains a growing concern for public health. In the US, incidence rates have been steadily rising since 2014, driven primarily by increases in advanced disease. The American Cancer Society (ACS) estimates that in 2025, more than 313,000 men will be diagnosed with prostate cancer and over 35,000 men will die from the disease.¹